Turning Innovation into Access
Getting a therapy approved is only the first step. Ensuring patients can access it is the real challenge. Our Market Access Solutions help pharma and biotech companies implement and scale pathways for real-world access.
From Early Access and Compassionate Use, to Patient Support Programs, we design and deliver managed and compliant solutions that support continuity of care, accelerate time to therapy, and support market adoption.
Our approach is built around each product’s access journey, whether following market withdrawal, supporting unlicensed use, or preparing for a phased launch, we integrate logistics, medical engagement, and real-world data collection into one coordinated framework.
We help translate strategic access plans into operational programs that deliver real patient reach and long-term market success.
Our Market Access Solutions help pharma and biotech partners navigate the path from clinical readiness to real-world availability. This is particularly relevant for therapies addressing rare, serious, or unmet medical needs. Our fully managed access models combine compliant logistics, regulatory expertise, medical engagement, and stakeholder coordination into one integrated patient-centric solution. We deliver the clarity, execution, and infrastructure needed to turn access strategy into measurable patient reach.
Access strategies only matter when they translate into operational programs that bring therapies to patients.
Our Market Access Solutions
From Early Access and Compassionate Use programs to Patient Support Programs, we design and operate compliant access pathways that help bring therapies to patients sooner.
Market Access ConsultingShaping access strategies for real-world success. We help translate market access strategies into operational reality. We advise on access model design, stakeholder engagement, distribution frameworks, and compliance infrastructure tailored to each product and region.
Managed Access ProgramStructured access. Centred on patients. From Early Access to Compassionate Use, we design and manage sponsor-driven programs that support ethical, compliant, and timely treatment access for patients in need. These programs are integrated into broader launch planning and tailored to each product’s access journey.
Patient Support ProgramEnabling continuity of care. Our tailored programs support patients throughout the treatment journey, from education and onboarding to coordination with healthcare providers and home care services. Designed in collaboration, our solutions are compliant, scalable, and always patient-focused.
Why Komtur
One Platform, Integrated Access
Komtur orchestrates access across regulatory, operational, stakeholder, and medical functions. We deliver Early Access, Compassionate Use, and Patient Support services in one sponsor-aligned, patient-centric solution.Lifecycle Continuity from Phase II to Post-Launch
Our models support access from first patient supply in Early or Compassionate Use through to commercialization. This enables agile launch sequencing and consistent patient continuity across stages.Global Reach with Local Adaptation
With 18 affiliates and deep regional expertise, we tailor implementation country by country. This helps ensure local realities don’t become global bottlenecks.Trusted in Complex Access Environments
Biotech and rare disease innovators rely on Komtur to bridge clinical readiness with operational access, even when data is limited or infrastructure is fragmented.Beyond Access: Supporting the Full Patient Journey
Our PSPs deliver education, coordination, and care continuity. We help patients start and stay on therapy while reinforcing outcomes and long-term treatment success.
Start your market access plan
Discuss access strategy, stakeholder engagement, and launch readiness with a Komtur specialist.